- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 5.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 5.66M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $1.03M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $1.02M |
| Capex | Q1 2026 · Mar 31, 2026 | $818K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1.01M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $3.61M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $4.13M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $60M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $60M |
| Short Term Debt | Q1 2026 · Mar 31, 2025 | $60M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $89.52M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $60.57M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $78.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $163.39M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $161.05M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $135.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $130.98M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.26B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.1B |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $2.09B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.42B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.26B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $2.22B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.71 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.76 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.71 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.76 |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.02M |
| Net Income | Q1 2026 · Mar 31, 2025 | $4.32M |